Tysabri may help heal MS patients' nerves

The Biogen Idec/Elan drug Tysabri may offer an important benefit that helps balance its risk of the potentially fatal brain infection primary multifocal leukoencephalopathy: A small new study suggests the drug promotes healing around the frayed nerves of multiple sclerosis patients. "What we have seen in these...data suggest that Tysabri may have the capacity to repair and possibly restore some of the damaged myelin sheath that protects nerve fibers," the study's lead author said in a Biogen statement. Release | Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.